Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Sodium Bicarbonate × Clear all

Phase

Phase NA 3 Phase EARLY_PHASE1 2 Phase 2 2 Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 340 Cyclophosphamide 332 Carboplatin 267 Gemcitabine 242 Paclitaxel 238 Nivolumab 227 Cisplatin 208 Radiotherapy 187 Bevacizumab 174 Dexamethasone 163 fludarabine 162 Docetaxel 160 Rituximab 153 Capecitabine 142 Oxaliplatin 129 Lenalidomide 129 Fluorouracil 123 Temozolomide 118 Cytarabine 114 Irinotecan 110 Cetuximab 109 Etoposide 108 venetoclax 104 fludarabine phosphate 104 Doxorubicin 96 130-nm albumin-bound paclitaxel 95 Injections 94 Azacitidine 93 Ipilimumab 92 Pemetrexed 89

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06661902 2026-02-17

BURN

University of Washington

Phase 1/2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡